BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 3494067)

  • 1. Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis.
    Arad-Dann H; Isenberg DA; Shoenfeld Y; Offen D; Sperling J; Sperling R
    J Immunol; 1987 Apr; 138(8):2463-8. PubMed ID: 3494067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
    Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
    Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against nuclear ribonucleoprotein (RNP) complexes.
    Sperling R
    Isr J Med Sci; 1988 Jul; 24(7):358-60. PubMed ID: 3042693
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-Sm and anti-RNP antibodies.
    Migliorini P; Baldini C; Rocchi V; Bombardieri S
    Autoimmunity; 2005 Feb; 38(1):47-54. PubMed ID: 15804705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of autoantibodies to extractable nuclear antigens in autoimmune diseases of rheumatic origin using immunoblotting--comparison with counter-electrophoresis].
    Hiepe F; Kiessig ST; Yamamoto K; Prokop G; Mielke F; Lukowsky A; Schlaak B; Miyamoto T; Apostoloff E
    Z Rheumatol; 1990; 49(5):304-9. PubMed ID: 2080688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-RNP monoclonal antibodies derived from a mouse strain with lupus-like autoimmunity.
    Billings PB; Allen RW; Jensen FC; Hoch SO
    J Immunol; 1982 Mar; 128(3):1176-80. PubMed ID: 6173424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear antibody with distinct specificity for polymyositis.
    Wolfe JF; Adelstein E; Sharp GC
    J Clin Invest; 1977 Jan; 59(1):176-8. PubMed ID: 318657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of ribonucleoprotein antibody.
    Rasmussen EK; Ullman S; Høier-Madsen M; Sørensen SF; Halberg P
    Arch Dermatol; 1987 May; 123(5):601-5. PubMed ID: 3495241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum and clinical significance of autoantibodies against transfer RNA.
    Ohosone Y; Ishida M; Takahashi Y; Matsumura M; Hirakata M; Kawahara Y; Nishikawa T; Mimori T
    Arthritis Rheum; 1998 Sep; 41(9):1625-31. PubMed ID: 9751095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to nuclear antigens in polymyositis: relationship to autoimmune 'overlap syndromes' and carcinoma.
    Venables PJ; Mumford PA; Maini RN
    Ann Rheum Dis; 1981 Jun; 40(3):217-23. PubMed ID: 6787993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)].
    Peltier AP; Gaudreau A; Amor B; Kahn MF; Ryckewaert A; Sany J; Haim T
    Nouv Presse Med; 1978 May; 7(21):1813-8. PubMed ID: 307737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myositis in other connective tissue disorders.
    Isenberg D
    Clin Rheum Dis; 1984 Apr; 10(1):151-74. PubMed ID: 6610527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
    Habets WJ; de Rooij DJ; Salden MH; Verhagen AP; van Eekelen CA; van de Putte LB; van Venrooij WJ
    Clin Exp Immunol; 1983 Oct; 54(1):265-76. PubMed ID: 6352106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.
    Habets WJ; de Rooij DJ; Hoet MH; van de Putte LB; van Venrooij WJ
    Clin Exp Immunol; 1985 Feb; 59(2):457-66. PubMed ID: 3884199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases.
    Wells JV; Webb J; Van Deventer M; Fry B; Pollard KM; Raftos J; Monk W; Nelson DS
    Clin Exp Immunol; 1979 Dec; 38(3):424-35. PubMed ID: 394890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear deposits of immunoglobulins in skin of patients with systemic lupus erythematosus.
    Shu S; Provost T; Croxdale MB; Reichlin M; Beutner EH
    Clin Exp Immunol; 1977 Feb; 27(2):238-44. PubMed ID: 300310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease.
    Muro Y; Sugiura K; Morita Y; Tomita Y
    Lupus; 2008 Mar; 17(3):171-6. PubMed ID: 18372356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.